Crossmark

Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size

Crossref DOI link: https://doi.org/10.1007/s13555-022-00756-4

Published Online: 2022-06-25

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gong, Xue https://orcid.org/0000-0001-8121-3566
Qiu, Tong https://orcid.org/0000-0001-6188-1030
Feng, Liwei https://orcid.org/0000-0001-8697-7127
Yang, Kaiying https://orcid.org/0000-0001-5847-1938
Dai, Shiyi https://orcid.org/0000-0002-3361-8363
Zhou, Jiangyuan https://orcid.org/0000-0001-6088-7633
Zhang, Xuepeng https://orcid.org/0000-0001-9840-1387
Chen, Siyuan https://orcid.org/0000-0003-0219-3558
Ji, Yi https://orcid.org/0000-0002-9289-9660
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03331744 at ClinicalTrials.gov

Documents that mention this clinical trial

Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size
https://doi.org/10.1007/s13555-022-00756-4

Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases
https://doi.org/10.1007/s12072-024-10756-5
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81400862)

National Natural Science Foundation of China (81401606)

Science Foundation for Excellent Youth Scholars of Sichuan University (2015SU04A15)

West China Hospital, Sichuan University (2019HXFH056)

West China Hospital, Sichuan University (2020HXFH048)

West China Hospital, Sichuan University (ZYJC21060)
License Information

Text and Data Mining valid from 2022-06-25

Version of Record valid from 2022-06-25
More Information

Article History

Received: 13 April 2022

Accepted: 6 June 2022

First Online: 25 June 2022

Document is current

Any future updates will be listed below